Pharmacologic efficacy of PU.1 inhibition by heterocyclic dications: a mechanistic analysis
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Heterocyclic dications are receiving increasing attention as targeted inhibitors of transcription factors. While many dications act as purely competitive inhibitors, some fail to displace protein efficiently at drug concentrations expected to saturate their DNA target. To achieve a mechanistic understanding of these non-competitive effects, we used a combination of dications, which are intrinsically fluorescent and spectrally-separated fluorescently labeled DNA to dissect complex interactions in multi-component drug/DNA/protein systems. Specifically, we interrogated site-specific binding by the transcription factor PU.1 and its perturbation by DB270, a furan-bisbenzimidazole-diamidine that strongly targets PU.1 binding sites yet poorly inhibits PU.1/DNA complexes. By titrating DB270 and/or cyanine-labeled DNA with protein or unlabeled DNA, and following the changes in their fluorescence polarization, we found direct evidence that DB270 bound protein independently of their mutual affinities for sequence-specific DNA. Each of the three species competed for the other two, and this interplay of mutually dependent equilibria abrogated DB270's inhibitory activity, which was substantively restored under conditions that attenuated DB270/PU.1 binding. PU.1 binding was consistent with DB270's poor inhibitory efficacy of PU.1 in vivo, while its isosteric selenophene analog (DB1976), which did not bind PU.1 and strongly inhibited the PU.1/DNA complex in vitro, fully antagonized PU.1-dependent transactivation in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide analysis of ETS-family DNA-binding in vitro and in vivo
Wei, G., Badis, G., Berger, M. F., Kivioja, T., Palin, K., Enge, M., Bonke, M., Jolma, A., Varjosalo, M., Gehrke, A. R., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.106 · Cited by 568 · cited 1×
“1-binding sites varies (21,22), and to establish FP measurements of DB270/DNA binding, we titrated DB270 with duplex DNA oligos harboring B or two other PU.”
MethodA new pattern for helix–turn–helix recognition revealed by the PU.l ETS–domain–DNA complex
Kodandapani, R., Pio, F., Ni, C.-Z., Piccialli, G., Klemsz, M., McKercher, S., Maki, R. A., & Ely, K. R. (1996) · Nature · doi:10.1038/380456a0 · Cited by 315
Mechanisms of in vivo binding site selection of the hematopoietic master transcription factor PU.1
Pham, T.-H., Minderjahn, J., Schmidl, C., Hoffmeister, H., Schmidhofer, S., Chen, W., Längst, G., Benner, C., & Rehli, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt355 · Cited by 102 · cited 1×
“1-binding sites varies (21,22), and to establish FP measurements of DB270/DNA binding, we titrated DB270 with duplex DNA oligos harboring B or two other PU.”
MethodEisenbeis, C. F., Singh, H., & Storb, U. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6452-6461.1993 · Cited by 38 · cited 2×
“1 in the murine Ig 2-4 enhancer element (5,20).”
BackgroundBase Coupling in Sequence-specific Site Recognition by the ETS Domain of Murine PU.1
Poon, G. M. K., & Macgregor, R. B. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00362-0 · Cited by 29 · cited 8×
“Since DB270 bound A-track DNA very tightly, the 10 nM of DB270 needed for reliable FP signals represented a prohibitively depleting concentration for titration at physiological salt concentrations.”
InfluentialSelf-citationA Thermodynamic Basis of DNA Sequence Selectivity by the ETS Domain of Murine PU.1
Poon, G. M. K., & Macgregor, R. B. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.09.046 · Cited by 19 · cited 1×
“1/DNA binding is only weakly sensitive to Na+ concentration (8,27,28), we took advantage of the lack of DB270/PU.”
BackgroundSelf-citation
Cited by
PU.1 controls fibroblast polarization and tissue fibrosis
Wohlfahrt, T., Rauber, S., Uebe, S., Luber, M., Soare, A., Ekici, A., Weber, S., Matei, A.-E., Chen, C.-W., Maier, C., et al. (2019) · Nature · doi:10.1038/s41586-019-0896-x · Cited by 187
“DB1976 35,36 is a heterocyclic diamidine that competitively blocks PU.1 binding to DNA with minimal effects on other ETS transcription factors due to its high specificity for AT-rich flanking sequences of the 5´-GGAA-3´ core (Fig.”
Self-citationPharmacological inhibition of the transcription factor PU.1 in leukemia
Antony-Debré, I., Paul, A., Leite, J., Mitchell, K., Kim, H. M., Carvajal, L. A., Todorova, T. I., Huang, K., Kumar, A., Farahat, A. A., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92504 · Cited by 120
“4 nM, in agreement with solution fluorescence anisotropy measurements (31).”
BackgroundSelf-citationStephens, D. C., & Poon, G. M. K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw528 · Cited by 37
“When fitted with a mechanistic model that accounts for probe depletion (17), the titration data (Table 1) afforded an unambiguous determination of absolute affinities (not IC50) of each protein for the variously methylated and unlabeled SC1 sites, free from interference from the fluorescent label if the titrations wer…”
BackgroundMethodInfluentialSelf-citationMartin-Estebane, M., & Gomez-Nicola, D. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00149 · Cited by 25
Taylor, S. J., Stauber, J., Bohorquez, O., Tatsumi, G., Kumari, R., Chakraborty, J., Bartholdy, B. A., Schwenger, E., Sundaravel, S., Farahat, A. A., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01911-7 · Cited by 22
Self-citationPTEN in Regulating Hematopoiesis and Leukemogenesis
Wu, Y., Zhu, H., & Wu, H. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036244 · Cited by 22
Metadata
- Authors
- Stephens, D. C., Kim, H. M., Kumar, A., Farahat, A. A., Boykin, D. W., & Poon, G. M. K.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-04-13
- Volume
- 44
- Issue
- 9
- Pages
- 4005-4013
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2338749310
- Cited by
- 38
- References
- 6
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.